FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Eric Borin has been named president of Medication Delivery Solutions (MDS) for BD, effective today.
Borin, 55, will be responsible for driving global strategic, operational and commercial performance of the MDS business unit and will report to Mike Garrison, executive vice president (EVP) and president of the Medical segment. Borin succeeds Rick Byrd who was recently promoted to EVP and president of the Interventional segment at BD. Since 2020, Borin has been president of the Pharmaceutical Systems business for BD.
“Eric has more than 25 years of BD leadership experience and is well suited to lead MDS — BD’s largest business unit by revenue,” said Garrison. “Over the past two years, Eric has led Pharmaceutical Systems to become one of the highest growth business units for BD and increased revenue well above BD’s long-term target. He has also positioned the business for the future by enabling the development of several innovative new drug delivery platforms to develop transformative solutions for the pharmaceutical industry and patients around the world.”
Borin joined BD in 1996 as a technical service manager in Pharmaceutical Systems and has held numerous leadership positions in the business. In 2010, Borin was named vice president (VP) and general manager (GM) of the North America region for Diabetes Care and then moved to the same role for Pharmaceutical Systems. In 2014, Borin was promoted to VP and GM of BD Rx, a business he led until BD divested it to Fresenius Kabi USA. In 2016, he rejoined Diabetes Care as VP and GM of the U.S. region and was then named VP and GM of Infusion Specialty Disposables in 2017, which is part of the MDS business unit. In 2020, Borin was promoted to president of Pharmaceutical Systems. Borin earned his Bachelor of Science in Mechanical Engineering from Manhattan College.